Psychotic episodes

A psychotic episode is a period during which a person's contact with shared reality breaks down — characterised by hallucinations, delusions, or disorganised thought severe enough to impair functioning. Episodes may last hours or extend into weeks, and their intensity can fluctuate within a single episode.

Many substance classes carry a risk of triggering psychosis. Stimulants — amphetamines and cocaine in particular — can produce paranoid psychosis during heavy or sustained use that closely resembles primary schizophrenia. Cannabis, especially high-THC preparations, is associated with acute transient episodes. Psychedelics and dissociatives can produce psychosis-like states during intoxication, which typically resolve as the substance clears. When symptoms persist beyond the period of direct intoxication, the clinical term is substance-induced psychotic disorder.

How it is done

In practice, the immediate priority during an acute episode is environment. A calm, low-stimulation setting and the presence of a steady, familiar person tend to reduce intensity more reliably than verbal intervention. Attempting to correct delusions or argue someone back to consensus reality typically escalates distress; a grounding presence without confrontation is the standard harm-reduction approach.

The trajectory varies with the substance and pattern of use. Episodes driven by acute intoxication tend to resolve as the drug metabolises, though this can take many hours. Episodes associated with sustained heavy use — particularly with stimulants or cannabis — may outlast the acute intoxication period by days, and may require clinical support rather than time and environment alone.

When it matters

An acute psychotic episode becomes a medical emergency when the person is at immediate risk of harming themselves or others, when physical symptoms accompany the psychological ones (extreme agitation, signs of overheating, cardiovascular distress), or when the episode does not follow the expected trajectory for the substance involved.

When the substance is unknown — as with an adulterant or a mislabelled compound — the baseline for expected trajectory does not exist, and clinical evaluation is the only reliable guide.

What it cannot tell you

A substance-related episode that resolves does not confirm the substance was the sole cause, and it does not rule out an underlying vulnerability. The timing criterion — symptoms appearing during or shortly after exposure and clearing once the substance does — is the primary basis for distinguishing substance-induced psychosis from primary psychotic illness. But that distinction often becomes clear only in retrospect.

Some individuals carry a pre-existing vulnerability that a substance can unmask. Whether an episode would have occurred without the substance is usually unknowable from the episode itself. Separately, a first episode of primary psychosis can coincide with substance use by chance — particularly in the age bracket when recreational experimentation and the typical onset of schizophrenia-spectrum conditions overlap.

A single episode that fully resolves does not establish which pathway applies. Only the longitudinal pattern — whether symptoms recur in the absence of substance use — can clarify this.